How effective is Mefloquine for Malaria? (by duration, gender, age)
Summary:
Overall ratings: 3.6/5 Long term ratings: 3.7/5
This is a phase IV clinical study of how effective Mefloquine (mefloquine hydrochloride) is for Malaria and for what kind of people. The study is created by eHealthMe from 21 Mefloquine users and is updated continuously.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
21 people are studied for taking Mefloquine in Malaria
What is Mefloquine?
Mefloquine has active ingredients of mefloquine hydrochloride. It is often used in malaria. eHealthMe is studying from 925 Mefloquine users for its effectiveness, alternative drugs and more.
What is Malaria?
Malaria (a parasitic disease due to mosquito bite) is found to be associated with 403 drugs and 308 conditions by eHealthMe.
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Mefloquine effectiveness for Malaria (number of people):
Overall:
- not at all: 1
- somewhat: 4
- moderate: 2
- high: 9
- very high: 5
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 0
- high: 1
- very high: 1
Gender of people who take Mefloquine for Malaria *:
- female: 42.86 %
- male: 57.14 %
Age of people who take Mefloquine for Malaria *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.76 %
- 20-29: 28.57 %
- 30-39: 42.86 %
- 40-49: 14.29 %
- 50-59: 4.76 %
- 60+: 4.76 %
Who find Mefloquine more effective for Malaria?
Gender of people who take Mefloquine for Malaria *:
- female: 35.71 %
- male: 64.29 %
Age of people who take Mefloquine for Malaria *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 35.71 %
- 30-39: 42.86 %
- 40-49: 7.14 %
- 50-59: 7.14 %
- 60+: 7.14 %
* Approximation only. Some reports may have incomplete information.
Do you take Mefloquine?
- You can start a phase IV clinical trial to monitor Mefloquine safety and effectiveness.How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of:
- Mefloquine (925 reports)
Treatments, associated drugs and conditions:
- Malaria (5,361 reports)
How the study uses the data?
The study is based on mefloquine hydrochloride (the active ingredients of Mefloquine) and Mefloquine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Multihance and Subcutaneous Nodule - 2 seconds ago
- Listeriosis and Polyhydramnios - 14 seconds ago
- Premature Menopause and Pain - 15 seconds ago
- Allegra and Akathisia - 19 seconds ago
- Lacunar Infarction and Electrocardiogram St-T Change - 22 seconds ago
- Pruritus Aggravated and Acne Pustular - 22 seconds ago
- Mercaptopurine and Blood Lactate Dehydrogenase Abnormal - 31 seconds ago
- Mevacor and Pancreatitis - 47 seconds ago
- Famvir and Effexor Xr drug interaction - 49 seconds ago
- Jakafi and Lung Carcinoma Cell Type Unspecified Stage Iv - 49 seconds ago